Progressive renal insufficiency following cardiac transplantation: cyclosporine, lipids, and hypertension
Open Access
- 31 July 1995
- journal article
- research article
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 26 (1), 193-201
- https://doi.org/10.1016/0272-6386(95)90174-4
Abstract
No abstract availableKeywords
Funding Information
- National Kidney Foundation
- National Institutes of Health (RROO645)
This publication has 22 references indexed in Scilit:
- Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusionKidney International, 1993
- Efficacy of Antihypertensive Medication in Orthotopic Heart Transplant Recipients and its Effect on Renal FunctionAngiology, 1992
- CYCLOSPORINE NEPHROTOXICITY IN CARDIAC ALLOGRAFT PATIENTSTransplantation, 1990
- LIPID ABNORMALITIES IN CYCLOSPORINE-PREDNISONE-TREATED RENAL TRANSPLANT RECIPIENTSTransplantation, 1989
- The long-term course of cyclosporine-associated chronic nephropathyKidney International, 1988
- Cyclosporine nephrotoxicityKidney International, 1986
- Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients.BMJ, 1986
- Cyclosporine-Associated Chronic NephropathyNew England Journal of Medicine, 1984
- Lipid Disorders in Renal Transplant RecipientsNephron, 1978
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976